These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 1865422)
81. Methimazole-induced severe aplastic anemia: unsuccessful treatment with recombinant human granulocyte-monocyte colony-stimulating factor. Escobar-Morreale HF; Bravo P; García-Robles R; García-Laraña J; de la Calle H; Sancho JM Thyroid; 1997 Feb; 7(1):67-70. PubMed ID: 9086574 [TBL] [Abstract][Full Text] [Related]
82. Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis. Champlin RE; Nimer SD; Oette D; Golde DW Prog Clin Biol Res; 1990; 338():143-50. PubMed ID: 2189137 [No Abstract] [Full Text] [Related]
83. Mesalazine-associated severe aplastic anemia successfully treated with antithymocyte globulin, cyclosporine and granulocyte colony-stimulating factor. Otsubo H; Kaito K; Sekita T; Shimada T; Kobayashi M; Hosoya T Int J Hematol; 1998 Dec; 68(4):445-8. PubMed ID: 9885444 [TBL] [Abstract][Full Text] [Related]
84. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. Frickhofen N; Kaltwasser JP; Schrezenmeier H; Raghavachar A; Vogt HG; Herrmann F; Freund M; Meusers P; Salama A; Heimpel H N Engl J Med; 1991 May; 324(19):1297-304. PubMed ID: 2017225 [TBL] [Abstract][Full Text] [Related]
85. Bone remodelling after growth factor and cyclosporine A therapy for aplastic anemia. Derfus BA; Csuka ME; Carrera GF; Hanson GA; Smith RE J Rheumatol; 1991 May; 18(5):738-42. PubMed ID: 1865422 [TBL] [Abstract][Full Text] [Related]
86. [Immunosuppressive therapy for aplastic anemia--review]. Xu CY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):348-52. PubMed ID: 15854308 [TBL] [Abstract][Full Text] [Related]
87. [Progress in biology and therapy of aplastic anemia and other conditions of bone marrow failure]. Robak T Postepy Hig Med Dosw; 1992; 46(1):21-51. PubMed ID: 1641375 [TBL] [Abstract][Full Text] [Related]
88. New approach of treatment of severe aplastic anemia. Cooperative Group on the Treatment of Aplastic Anemia. Gluckman E; Bourdeau-Esperou H; Boogaerts M; Briere J; Navarro J; Leverger G; Leporrier M; Reiffers J; Janvier M; Michallet M Bone Marrow Transplant; 1991; 7 Suppl 2():106-7. PubMed ID: 1878666 [No Abstract] [Full Text] [Related]
89. Human recombinant hemopoietic growth factors G-CSF and GM-CSF: first results of clinical trials. Nissen-Druey C Nouv Rev Fr Hematol (1978); 1989; 31(2):99-101. PubMed ID: 2475852 [No Abstract] [Full Text] [Related]
90. [Current status of the drug therapy of sever aplastic anemia]. Zhang MH Zhonghua Nei Ke Za Zhi; 1991 May; 30(5):302-4. PubMed ID: 1879244 [No Abstract] [Full Text] [Related]
92. Use of hematopoietic growth factors for treatment of aplastic anemia. Kojima S Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S36-8. PubMed ID: 8971406 [TBL] [Abstract][Full Text] [Related]
93. Clinical trials of granulocyte-macrophage colony-stimulating factor for the treatment of aplastic anemia. Vadhan-Raj S Immunol Ser; 1992; 57():661-70. PubMed ID: 1504150 [No Abstract] [Full Text] [Related]
94. What is the most effective treatment of children with severe aplastic anemia who lack a matched sibling donor? Johnson FL Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S39-44. PubMed ID: 8971407 [TBL] [Abstract][Full Text] [Related]
95. Treatment of acquired severe aplastic anemia. Katsanis E; Ramsay NK Am J Pediatr Hematol Oncol; 1989; 11(3):360-7. PubMed ID: 2675662 [TBL] [Abstract][Full Text] [Related]